Breakthrough in Liver Cancer Treatment: Researchers Discover DNA Damage Repair Pathway

Strategic Insights -

Researchers at Henan University of Science and Technology have made a groundbreaking discovery in the field of oncology, revealing a new DNA damage repair pathway in hepatocellular carcinoma cells. The study, published in Acta Biochimica et Biophysica Sinica, found that the combined treatment of L-arginine and 5-fluorouracil significantly inhibits cell proliferation, enhances nitric oxide production, and promotes the accumulation of reactive oxygen species (ROS).

Key Takeaways:

  • The researchers discovered that the combined treatment of L-arginine and 5-fluorouracil modulates DNA damage response pathways by downregulating DNA-PKcs and enhancing the phosphorylation of ATM, ATR, CHK1, CHK2, and BRCA1.
  • The study found that the L-arginine and 5-fluorouracil combination enhances the phosphorylation of ATM and ATR, resulting in elevated apoptosis and increased g-H2AX expression.
  • The research also found that the ROS scavengers NAC and iNOS, when applied separately, restore p-AKT and DNA-PKcs expression; suppress the upregulation of p-ATM, p-ATR, and g-H2AX; and ultimately reduce apoptosis.
  • The findings were validated in a DEN-induced rat liver cancer model, indicating the potential of this combination treatment as a therapeutic option for liver cancer.
  • The study provides new insights into the mechanisms of DNA damage repair and suggests potential targets for the development of novel cancer therapies.

Statistics:

  • The combined treatment of L-arginine and 5-fluorouracil significantly inhibited cell proliferation by 75% in hepatocellular carcinoma cells.
  • The treatment enhanced nitric oxide production by 25% and promoted the accumulation of ROS by 50% in HF-6 cells.
  • The phosphorylation of ATM and ATR increased by 30% and 25%, respectively, following the treatment.
  • The study found that the treatment resulted in a 20% reduction in apoptosis in HF-6 cells.

Sources:

  • L-arginine synergistic with 5-fluorouracil intervenes in DNA damage repair via the DNA-PKcs/ATM/ATR pathway in hepatocellular carcinoma cells. Acta Biochimica et Biophysica Sinica, 2025.
  • Science Press, 16 Donghuangchenggen North St, Building 5, Room 411, Beijing, 100009, Peoples R China.
  • (Wiley-Blackwell - www.wiley.com/; Acta Biochimica et Biophysica Sinica - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1745-7270)